Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
Stopped Study withdrawn.
Conditions
- Brain and Central Nervous System Tumors
Interventions
- DRUG: Isotretinoin
- DRUG: Procarbazine Hydrochloride
Sponsor
M.D. Anderson Cancer Center
Collaborators